Differential effect of the benzophenanthridine alkaloids sanguinarine and chelerythrine on glycine transporters

This publication has 52 references indexed in Scilit:

• Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain
  Pharmacology & Therapeutics, 2009
• Spinal Antiallodynia Action of Glycine Transporter Inhibitors in Neuropathic Pain Models in Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Activation of dorsal periaqueductal gray by glycine produces long lasting hyponociception in rats without overt defensive behaviors
  Life Sciences, 2008
• Chelerythrine and Sanguinarine Dock at Distinct Sites on BclXL that are Not the Classic BH3 Binding Cleft
  Journal of Molecular Biology, 2006
• Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain
  Nature, 2003
• DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique
  Chemico-Biological Interactions, 2002
• Chelerythrine is a potent and specific inhibitor of protein kinase C
  Biochemical and Biophysical Research Communications, 1990
• Sanguinarine: a monofunctional intercalating alkaloid
  FEBS Letters, 1982
• Inhibition of Na,K‐ATPase activity and ouabain binding by sanguinarine
  Drug Development Research, 1981
• Effect of sanguinarine, a benzophenanthridine alkaloid, on frog skin potential difference and short circuit current
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1978